TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3130527
log Bayes Factor = 73.5466
Chromosome 6   position 31,198,987  (GRCh37) Explore rs3130527 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
E10.9 Without complications
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
L40 Psoriasis
0.000 0.000 1.000
E10.3 With ophthalmic complications
0.000 0.000 1.000
E16 Other disorders of pancreatic internal secretion
0.000 0.001 0.999
E16.2 Hypoglycaemia, unspecified
0.000 0.001 0.999
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.001 0.999
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.001 0.999
L40.5 Arthropathic psoriasis
0.000 0.001 0.999
E14 Unspecified diabetes mellitus
0.000 0.001 0.999
E11.9 Without complications
0.000 0.005 0.995
E78.0 Pure hypercholesterolaemia
0.000 0.017 0.983
L40-L45 Papulosquamous disorders
0.000 0.020 0.980
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.020 0.980
E70-E90 Metabolic disorders
0.000 0.023 0.977
L43 Lichen planus
0.000 0.023 0.977
E14.9 Without complications
0.000 0.024 0.976
L43.9 Lichen planus, unspecified
0.000 0.027 0.973
E11.4 With neurological complications
0.000 0.028 0.972
E13 Other specified diabetes mellitus
0.000 0.036 0.964
E14.3 With ophthalmic complications
0.000 0.050 0.950
E10.4 With neurological complications
0.000 0.054 0.946
E10.1 With ketoacidosis
0.000 0.061 0.939
E13.9 Without complications
0.000 0.064 0.936
E11.0 With coma
0.000 0.083 0.917
E11.5 With peripheral circulatory complications
0.000 0.084 0.916
L40.0 Psoriasis vulgaris
0.000 0.096 0.904
E10.2 With renal complications
0.000 0.100 0.900
E11.6 With other specified complications
0.000 0.102 0.898
E78.2 Mixed hyperlipidaemia
0.000 0.122 0.878
E11.2 With renal complications
0.000 0.126 0.874
E14.8 With unspecified complications
0.000 0.139 0.861
E10.8 With unspecified complications
0.000 0.139 0.861
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.144 0.856
E14.1 With ketoacidosis
0.000 0.168 0.832
L40.1 Generalised pustular psoriasis
0.000 0.180 0.820
E11.3 With ophthalmic complications
0.000 0.182 0.818
E11.1 With ketoacidosis
0.000 0.183 0.817
L43.8 Other lichen planus
0.000 0.192 0.808
E16.1 Other hypoglycaemia
0.000 0.192 0.808
E10.6 With other specified complications
0.000 0.193 0.807
E10.0 With coma
0.000 0.197 0.803
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.207 0.793
L40.8 Other psoriasis
0.000 0.217 0.782
E74 Other disorders of carbohydrate metabolism
0.000 0.219 0.781
E10.5 With peripheral circulatory complications
0.000 0.219 0.781
E14.4 With neurological complications
0.000 0.233 0.767
E85 Amyloidosis
0.000 0.243 0.757
E40-E46 Malnutrition
0.000 0.248 0.752
E79 Disorders of purine and pyrimidine metabolism
0.000 0.252 0.748
E14.5 With peripheral circulatory complications
0.000 0.263 0.737
E78.8 Other disorders of lipoprotein metabolism
0.000 0.266 0.734
E78.4 Other hyperlipidaemia
0.000 0.268 0.732
E11.8 With unspecified complications
0.000 0.270 0.729
E65-E68 Obesity and other hyperalimentation
0.000 0.273 0.727
K51.9 Ulcerative colitis, unspecified
0.721 0.279 0.000
E78.6 Lipoprotein deficiency
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
L40.4 Guttate psoriasis
0.000 0.283 0.717
L40.2 Acrodermatitis continua
0.000 0.283 0.717
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.283 0.717
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.283 0.717
E16.4 Abnormal secretion of gastrin
0.000 0.283 0.717
E16.3 Increased secretion of glucagon
0.000 0.283 0.717
E15 Nondiabetic hypoglycaemic coma
0.000 0.283 0.716
E14.7 With multiple complications
0.000 0.284 0.716
E14.2 Withrenal complications
0.000 0.284 0.716
E14.0 With coma
0.000 0.284 0.716
E84 Cystic fibrosis
0.000 0.285 0.715
K51 Ulcerative colitis
0.711 0.289 0.000
E13.3 With ophthalmic complications
0.000 0.293 0.707
L40.3 Pustulosis palmaris et plantaris
0.000 0.294 0.706
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.297 0.703
L44 Other papulosquamous disorders
0.000 0.297 0.703
L41 Parapsoriasis
0.000 0.297 0.703
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.297 0.703
E78.3 Hyperchylomicronaemia
0.000 0.297 0.703
E14.6 With other specified complications
0.000 0.299 0.701
E77 Disorders of glycoprotein metabolism
0.000 0.299 0.700
E76 Disorders of glycosaminoglycan metabolism
0.000 0.299 0.700
E72 Other disorders of amino-acid metabolism
0.000 0.299 0.700
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.299 0.700
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.299 0.700
L43.3 Subacute (active) lichen planus
0.000 0.300 0.700
L43.2 Lichenoid drug reaction
0.000 0.300 0.700
L43.1 Bullous lichen planus
0.000 0.300 0.700
L43.0 Hypertrophic lichen planus
0.000 0.300 0.700
E89.3 Postprocedural hypopituitarism
0.000 0.302 0.698
E13.8 With unspecified complications
0.000 0.309 0.691
E13.7 With multiple complications
0.000 0.309 0.691
E13.6 With other specified complications
0.000 0.309 0.691
E13.5 With peripheral circulatory complications
0.000 0.309 0.691
E13.4 With neurological complications
0.000 0.309 0.691
E13.2 With renal complications
0.000 0.309 0.691
E13.1 With ketoacidosis
0.000 0.309 0.691
E13.0 With coma
0.000 0.309 0.691
L42 Pityriasis rosea
0.000 0.311 0.689
E78.1 Pure hyperglyceridaemia
0.000 0.315 0.684
E70 Disorders of aromatic amino-acid metabolism
0.000 0.318 0.682
K51.8 Other ulcerative colitis
0.668 0.332 0.000
K90 Intestinal malabsorption
0.000 0.358 0.642
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.359 0.641
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.360 0.640
K51.4 Pseudopolyposis of colon
0.632 0.368 0.000
E78.5 Hyperlipidaemia, unspecified
0.000 0.374 0.626
E89.2 Postprocedural hypoparathyroidism
0.000 0.378 0.622
K51.3 Ulcerative (chronic) rectosigmoiditis
0.619 0.381 0.000
E50-E64 Other nutritional deficiencies
0.000 0.384 0.616
K51.5 Mucosal proctocolitis
0.603 0.397 0.000
E85.4 Organ-limited amyloidosis
0.000 0.397 0.603
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.416 0.584
E89.4 Postprocedural ovarian failure
0.000 0.418 0.582
K51.1 Ulcerative (chronic) ileocolitis
0.576 0.424 0.000
E46 Unspecified protein-energy malnutrition
0.000 0.425 0.575
K51.2 Ulcerative (chronic) proctitis
0.573 0.427 0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.432 0.568
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.432 0.568
E89.5 Postprocedural testicular hypofunction
0.000 0.432 0.568
E89.1 Postprocedural hypoinsulinaemia
0.000 0.432 0.568
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.440 0.560
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.440 0.560
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.440 0.560
E74.2 Disorders of galactose metabolism
0.000 0.440 0.560
E74.1 Disorders of fructose metabolism
0.000 0.440 0.560
E74.0 Glycogen storage disease
0.000 0.440 0.560
E85.9 Amyloidosis, unspecified
0.000 0.441 0.559
E00-E07 Disorders of thyroid gland
0.001 0.448 0.552
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.457 0.542
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.457 0.542
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.457 0.542
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.460 0.539
E45 Retarded development following protein-energy malnutrition
0.000 0.460 0.539
E43 Unspecified severe protein-energy malnutrition
0.000 0.460 0.539
E42 Marasmic kwashiorkor
0.000 0.460 0.539
E41 Nutritional marasmus
0.000 0.460 0.539
E40 Kwashiorkor
0.000 0.460 0.539
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.463 0.536
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.463 0.536
E79.1 Lesch-Nyhan syndrome
0.000 0.463 0.536
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.464 0.536
E65 Localised adiposity
0.000 0.468 0.532
E85.8 Other amyloidosis
0.000 0.468 0.531
E85.3 Secondary systemic amyloidosis
0.000 0.469 0.531
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.470 0.530
E84.9 Cystic fibrosis, unspecified
0.000 0.472 0.528
E05.9 Thyrotoxicosis, unspecified
0.000 0.477 0.523
E66 Obesity
0.000 0.478 0.522
E67 Other hyperalimentation
0.000 0.478 0.521
E68 Sequelae of hyperalimentation
0.000 0.478 0.521
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E84.8 Cystic fibrosis with other manifestations
0.000 0.487 0.513
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.487 0.513
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.487 0.513
K90.9 Intestinal malabsorption, unspecified
0.000 0.490 0.510
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.493 0.507
E75.5 Other lipid storage disorders
0.000 0.493 0.506
E75.6 Lipid storage disorder, unspecified
0.000 0.496 0.504
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.496 0.504
E75.3 Sphingolipidosis, unspecified
0.000 0.496 0.504
E75.2 Other sphingolipidosis
0.000 0.496 0.504
E75.1 Other gangliosidosis
0.000 0.496 0.504
E75.0 GM2 gangliosidosis
0.000 0.496 0.504
L41.9 Parapsoriasis, unspecified
0.000 0.496 0.504
L41.8 Other parapsoriasis
0.000 0.496 0.504
L41.5 Retiform parapsoriasis
0.000 0.496 0.504
L41.4 Large plaque parapsoriasis
0.000 0.496 0.504
L41.3 Small plaque parapsoriasis
0.000 0.496 0.504
L41.2 Lymphomatoid papulosis
0.000 0.496 0.504
L41.1 Pityriasis lichenoides chronica
0.000 0.496 0.504
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.496 0.504
L44.9 Papulosquamous disorder, unspecified
0.000 0.496 0.504
L44.8 Other specified papulosquamous disorders
0.000 0.496 0.504
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.496 0.504
L44.3 Lichen ruber moniliformis
0.000 0.496 0.504
L44.2 Lichen striatus
0.000 0.496 0.504
L44.1 Lichen nitidus
0.000 0.496 0.504
L44.0 Pityriasis rubra pilaris
0.000 0.496 0.504
E88 Other metabolic disorders
0.000 0.496 0.503
E71.3 Disorders of fatty-acid metabolism
0.000 0.498 0.502
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.498 0.502
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.498 0.502
E71.0 Maple-syrup-urine disease
0.000 0.498 0.502
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.498 0.502
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.498 0.502
E72.5 Disorders of glycine metabolism
0.000 0.498 0.502
E72.4 Disorders of ornithine metabolism
0.000 0.498 0.502
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.498 0.502
E72.2 Disorders of urea cycle metabolism
0.000 0.498 0.502
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.498 0.502
E72.0 Disorders of amino-acid transport
0.000 0.498 0.502
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.498 0.502
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.498 0.502
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.498 0.502
E76.2 Other mucopolysaccharidoses
0.000 0.498 0.502
E76.1 Mucopolysaccharidosis, type II
0.000 0.498 0.502
E76.0 Mucopolysaccharidosis, type I
0.000 0.498 0.502
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.498 0.502
E77.8 Other disorders of glycoprotein metabolism
0.000 0.498 0.502
E77.1 Defects in glycoprotein degradation
0.000 0.498 0.502
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.498 0.502
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.503 0.497
K90.8 Other intestinal malabsorption
0.000 0.510 0.490
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.511 0.489
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.511 0.489
E70.2 Disorders of tyrosine metabolism
0.000 0.511 0.489
E70.1 Other hyperphenylalaninaemias
0.000 0.511 0.489
E70.0 Classical phenylketonuria
0.000 0.511 0.489
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.518 0.482
E61 Deficiency of other nutrient elements
0.000 0.526 0.474
E70.3 Albinism
0.000 0.529 0.471
E66.0 Obesity due to excess calories
0.000 0.535 0.465
E55 Vitamin D deficiency
0.000 0.538 0.462
K90.3 Pancreatic steatorrhoea
0.000 0.540 0.460
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.540 0.460
K90.1 Tropical sprue
0.000 0.540 0.460
E73 Lactose intolerance
0.004 0.544 0.452
K51.0 Ulcerative (chronic) enterocolitis
0.450 0.550 0.000
E83.1 Disorders of iron metabolism
0.447 0.552 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.553 0.447
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.558 0.441
E63 Other nutritional deficiencies
0.000 0.558 0.441
E56 Other vitamin deficiencies
0.000 0.558 0.441
E51 Thiamine deficiency
0.000 0.558 0.441
E50 Vitamin A deficiency
0.000 0.558 0.441
E60 Dietary zinc deficiency
0.000 0.558 0.441
E59 Dietary selenium deficiency
0.000 0.558 0.441
E58 Dietary calcium deficiency
0.000 0.558 0.441
E54 Ascorbic acid deficiency
0.000 0.558 0.441
E52 Niacin deficiency [pellagra]
0.000 0.558 0.441
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.001 0.604 0.395
E00 Congenital iodine-deficiency syndrome
0.001 0.604 0.395
E44.1 Mild protein-energy malnutrition
0.000 0.613 0.387
E44.0 Moderate protein-energy malnutrition
0.000 0.613 0.387
E05.5 Thyroid crisis or storm
0.000 0.615 0.385
E05.4 Thyrotoxicosis factitia
0.000 0.615 0.385
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.615 0.385
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.615 0.385
E80.2 Other porphyria
0.000 0.618 0.381
E05.8 Other thyrotoxicosis
0.000 0.619 0.381
E66.1 Drug-induced obesity
0.000 0.626 0.374
E67.8 Other specified hyperalimentation
0.000 0.626 0.374
E67.3 Hypervitaminosis D
0.000 0.626 0.374
E67.2 Megavitamin-B6 syndrome
0.000 0.626 0.374
E67.1 Hypercarotenaemia
0.000 0.626 0.374
E67.0 Hypervitaminosis A
0.000 0.626 0.374
E06 Thyroiditis
0.000 0.626 0.373
E61.1 Iron deficiency
0.000 0.629 0.371
E88.2 Lipomatosis, not elsewhere classified
0.000 0.632 0.368
E88.8 Other specified metabolic disorders
0.000 0.633 0.367
E88.9 Metabolic disorder, unspecified
0.000 0.639 0.361
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.643 0.357
E80.5 Crigler-Najjar syndrome
0.000 0.643 0.357
E80.3 Defects of catalase and peroxydase
0.000 0.643 0.357
E80.0 Hereditary erythropoietic porphyria
0.000 0.643 0.357
E02 Subclinical iodine-deficiency hypothyroidism
0.001 0.648 0.352
E55.9 Vitamin D deficiency, unspecified
0.000 0.648 0.352
E83 Disorders of mineral metabolism
0.277 0.657 0.066
E80.6 Other disorders of bilirubin metabolism
0.000 0.657 0.343
E61.2 Magnesium deficiency
0.000 0.658 0.342
E61.9 Deficiency of nutrient element, unspecified
0.000 0.660 0.340
E61.8 Deficiency of other specified nutrient elements
0.000 0.660 0.340
E61.7 Deficiency of multiple nutrient elements
0.000 0.660 0.340
E61.6 Vanadium deficiency
0.000 0.660 0.340
E61.5 Molybdenum deficiency
0.000 0.660 0.340
E61.4 Chromium deficiency
0.000 0.660 0.340
E61.3 Manganese deficiency
0.000 0.660 0.340
E61.0 Copper deficiency
0.000 0.660 0.340
E88.3 Tumour lysis syndrome
0.000 0.661 0.339
E80.1 Porphyria cutanea tarda
0.000 0.661 0.338
E55.0 Rickets, active
0.000 0.669 0.331
E73.8 Other lactose intolerance
0.003 0.673 0.324
E73.1 Secondary lactase deficiency
0.003 0.673 0.324
E73.0 Congenital lactase deficiency
0.003 0.673 0.324
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.674 0.326
E06.9 Thyroiditis, unspecified
0.000 0.683 0.317
E50.9 Vitamin A deficiency, unspecified
0.000 0.683 0.316
E50.8 Other manifestations of vitamin A deficiency
0.000 0.683 0.316
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.683 0.316
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.683 0.316
E50.5 Vitamin A deficiency with night blindness
0.000 0.683 0.316
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.683 0.316
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.683 0.316
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.683 0.316
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.683 0.316
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.683 0.316
E51.9 Thiamine deficiency, unspecified
0.000 0.683 0.316
E51.8 Other manifestations of thiamine deficiency
0.000 0.683 0.316
E51.2 Wernicke's encephalopathy
0.000 0.683 0.316
E51.1 Beriberi
0.000 0.683 0.316
E56.9 Vitamin deficiency, unspecified
0.000 0.683 0.316
E56.8 Deficiency of other vitamins
0.000 0.683 0.316
E56.1 Deficiency of vitamin K
0.000 0.683 0.316
E56.0 Deficiency of vitamin E
0.000 0.683 0.316
E63.9 Nutritional deficiency, unspecified
0.000 0.683 0.316
E63.8 Other specified nutritional deficiencies
0.000 0.683 0.316
E63.1 Imbalance of constituents of food intake
0.000 0.683 0.316
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.683 0.316
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.683 0.316
E64.8 Sequelae of other nutritional deficiencies
0.000 0.683 0.316
E64.3 Sequelae of rickets
0.000 0.683 0.316
E64.2 Sequelae of vitamin C deficiency
0.000 0.683 0.316
E64.1 Sequelae of vitamin A deficiency
0.000 0.683 0.316
E64.0 Sequelae of protein-energy malnutrition
0.000 0.683 0.316
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.698 0.302
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.001 0.716 0.284
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.001 0.716 0.284
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.001 0.716 0.284
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.001 0.716 0.284
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.001 0.716 0.284
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.001 0.716 0.284
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.001 0.716 0.284
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.001 0.716 0.284
E88.1 Lipodystrophy, not elsewhere classified
0.001 0.725 0.275
E83.3 Disorders of phosphorus metabolism
0.257 0.730 0.013
E07 Other disorders of thyroid
0.000 0.731 0.268
E06.4 Drug-induced thyroiditis
0.000 0.732 0.268
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.732 0.268
E06.1 Subacute thyroiditis
0.000 0.732 0.268
E06.0 Acute thyroiditis
0.000 0.732 0.268
E83.9 Disorder of mineral metabolism, unspecified
0.224 0.736 0.040
E06.5 Other chronic thyroiditis
0.000 0.741 0.258
E83.8 Other disorders of mineral metabolism
0.199 0.754 0.048
E83.2 Disorders of zinc metabolism
0.199 0.754 0.048
E83.0 Disorders of copper metabolism
0.199 0.754 0.048
E53 Deficiency of other B group vitamins
0.000 0.768 0.232
E03 Other hypothyroidism
0.002 0.797 0.200
E07.1 Dyshormogenetic goitre
0.000 0.807 0.193
E07.0 Hypersecretion of calcitonin
0.000 0.807 0.193
M45.X9 Ankylosing spondylitis (Site unspecified)
0.000 0.809 0.191
E86 Volume depletion
0.000 0.817 0.183
E07.8 Other specified disorders of thyroid
0.000 0.820 0.179
E53.1 Pyridoxine deficiency
0.000 0.833 0.166
E53.0 Riboflavin deficiency
0.000 0.833 0.166
E80.4 Gilbert's syndrome
0.000 0.839 0.160
M45 Ankylosing spondylitis
0.000 0.842 0.158
E06.3 Autoimmune thyroiditis
0.000 0.843 0.156
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.002 0.847 0.151
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.000 0.848 0.152
E20-E35 Disorders of other endocrine glands
0.000 0.853 0.147
E89.0 Postprocedural hypothyroidism
0.000 0.854 0.146
E03.5 Myxoedema coma
0.002 0.854 0.144
E03.4 Atrophy of thyroid (acquired)
0.002 0.854 0.144
E03.3 Postinfectious hypothyroidism
0.002 0.854 0.144
E03.0 Congenital hypothyroidism with diffuse goitre
0.002 0.854 0.144
E53.9 Vitamin B deficiency, unspecified
0.000 0.855 0.144
E03.1 Congenital hypothyroidism without goitre
0.002 0.860 0.138
E24 Cushing's syndrome
0.000 0.870 0.130
E03.8 Other specified hypothyroidism
0.002 0.873 0.125
G35 Multiple sclerosis
0.120 0.880 0.000
E26 Hyperaldosteronism
0.000 0.883 0.117
E24.9 Cushing's syndrome, unspecified
0.000 0.885 0.115
M45.X2 Ankylosing spondylitis (Cervical region)
0.000 0.886 0.114
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)
0.000 0.886 0.113
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.000 0.886 0.113
M45.X6 Ankylosing spondylitis (Lumbar region)
0.000 0.886 0.113
M45.X5 Ankylosing spondylitis (Thoracolumbar region)
0.000 0.886 0.113
M45.X4 Ankylosing spondylitis (Thoracic region)
0.000 0.886 0.113
M45.X3 Ankylosing spondylitis (Cervicothoracic region)
0.000 0.886 0.113
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)
0.000 0.886 0.113
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.888 0.111
E66.8 Other obesity
0.000 0.890 0.110
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.894 0.106
E32 Diseases of thymus
0.000 0.894 0.106
E30 Disorders of puberty, not elsewhere classified
0.000 0.894 0.106
E25 Adrenogenital disorders
0.000 0.894 0.106
E83.4 Disorders of magnesium metabolism
0.054 0.895 0.050
E24.2 Drug-induced Cushing's syndrome
0.000 0.901 0.099
E31 Polyglandular dysfunction
0.000 0.901 0.099
E07.9 Disorder of thyroid, unspecified
0.000 0.904 0.096
E26.0 Primary hyperaldosteronism
0.000 0.904 0.095
E29 Testicular dysfunction
0.000 0.905 0.095
E83.5 Disorders of calcium metabolism
0.084 0.906 0.010
E24.8 Other Cushing's syndrome
0.000 0.906 0.093
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.906 0.093
E24.3 Ectopic ACTH syndrome
0.000 0.906 0.093
E24.1 Nelson's syndrome
0.000 0.906 0.093
E24.0 Pituitary-dependent Cushing's disease
0.000 0.906 0.093
E23 Hypofunction and other disorders of pituitary gland
0.000 0.909 0.091
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.912 0.088
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.913 0.087
E22 Hyperfunction of pituitary gland
0.000 0.913 0.087
G35-G37 Demyelinating diseases of the central nervous system
0.087 0.913 0.000
E20 Hypoparathyroidism
0.000 0.914 0.086
E73.9 Lactose intolerance, unspecified
0.010 0.914 0.076
E26.9 Hyperaldosteronism, unspecified
0.000 0.916 0.084
E26.8 Other hyperaldosteronism
0.000 0.916 0.084
E26.1 Secondary hyperaldosteronism
0.000 0.916 0.084
G37 Other demyelinating diseases of central nervous system
0.081 0.919 0.000
E34 Other endocrine disorders
0.000 0.920 0.080
C83.3 Large cell (diffuse)
0.000 0.920 0.080
G37.9 Demyelinating disease of central nervous system, unspecified
0.078 0.922 0.000
K90-K93 Other diseases of the digestive system
0.000 0.923 0.077
E28 Ovarian dysfunction
0.000 0.924 0.076
E25.9 Adrenogenital disorder, unspecified
0.000 0.924 0.076
E25.8 Other adrenogenital disorders
0.000 0.924 0.076
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.924 0.076
E30.9 Disorder of puberty, unspecified
0.000 0.924 0.076
E30.8 Other disorders of puberty
0.000 0.924 0.076
E30.1 Precocious puberty
0.000 0.924 0.076
E30.0 Delayed puberty
0.000 0.924 0.076
E32.9 Disease of thymus, unspecified
0.000 0.924 0.076
E32.8 Other diseases of thymus
0.000 0.924 0.076
E32.1 Abscess of thymus
0.000 0.924 0.076
E32.0 Persistent hyperplasia of thymus
0.000 0.924 0.076
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.924 0.076
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.924 0.076
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.924 0.076
E23.6 Other disorders of pituitary gland
0.000 0.924 0.076
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.927 0.073
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.928 0.072
E31.9 Polyglandular dysfunction, unspecified
0.000 0.929 0.071
E31.8 Other polyglandular dysfunction
0.000 0.929 0.071
E31.1 Polyglandular hyperfunction
0.000 0.929 0.071
E22.1 Hyperprolactinaemia
0.000 0.929 0.070
C82.0 Small cleaved cell, follicular
0.000 0.931 0.069
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.931 0.069
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.931 0.069
E29.8 Other testicular dysfunction
0.000 0.932 0.068
E29.0 Testicular hyperfunction
0.000 0.932 0.068
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.932 0.067
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.932 0.067
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.933 0.067
E23.7 Disorder of pituitary gland, unspecified
0.000 0.934 0.066
E29.1 Testicular hypofunction
0.000 0.934 0.066
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.935 0.065
E23.1 Drug-induced hypopituitarism
0.000 0.935 0.065
E31.0 Autoimmune polyglandular failure
0.000 0.936 0.064
C82.2 Large cell, follicular
0.000 0.937 0.063
E21.4 Other specified disorders of parathyroid gland
0.000 0.937 0.063
E21.2 Other hyperparathyroidism
0.000 0.937 0.063
C82.6 Cutaneous follicle centre lymphoma
0.000 0.937 0.063
C82.5 Diffuse follicle centre lymphoma
0.000 0.937 0.063
C82.4 Follicular lymphoma grade IIIb
0.000 0.937 0.063
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.937 0.063
E22.8 Other hyperfunction of pituitary gland
0.000 0.937 0.063
E20.8 Other hypoparathyroidism
0.000 0.938 0.062
E20.1 Pseudohypoparathyroidism
0.000 0.938 0.062
E20.0 Idiopathic hypoparathyroidism
0.000 0.938 0.062
C85.1 B-cell lymphoma, unspecified
0.000 0.938 0.062
G36 Other acute disseminated demyelination
0.062 0.938 0.000
E29.9 Testicular dysfunction, unspecified
0.000 0.939 0.060
G37.8 Other specified demyelinating diseases of central nervous system
0.060 0.940 0.000
N18 Chronic renal failure
0.000 0.941 0.059
N18.9 Chronic renal failure, unspecified
0.000 0.941 0.059
C83.7 Burkitt's tumour
0.000 0.942 0.058
G37.5 Concentric sclerosis [Balo]
0.058 0.942 0.000
G37.4 Subacute necrotising myelitis
0.058 0.942 0.000
G37.2 Central pontine myelinolysis
0.058 0.942 0.000
G37.1 Central demyelination of corpus callosum
0.058 0.942 0.000
G37.0 Diffuse sclerosis
0.058 0.942 0.000
E34.5 Androgen resistance syndrome
0.000 0.942 0.058
E34.4 Constitutional tall stature
0.000 0.942 0.058
E34.3 Short stature, not elsewhere classified
0.000 0.942 0.058
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.942 0.058
E34.1 Other hypersecretion of intestinal hormones
0.000 0.942 0.058
E34.8 Other specified endocrine disorders
0.000 0.943 0.056
E21.3 Hyperparathyroidism, unspecified
0.000 0.944 0.056
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.944 0.056
N18.3 Chronic kidney disease, stage 3
0.000 0.944 0.056
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.944 0.056
M13.99 Arthritis, unspecified (Site unspecified)
0.000 0.945 0.055
E28.9 Ovarian dysfunction, unspecified
0.000 0.945 0.055
E28.8 Other ovarian dysfunction
0.000 0.945 0.055
E28.1 Androgen excess
0.000 0.945 0.055
E28.0 Oestrogen excess
0.000 0.945 0.055
E22.0 Acromegaly and pituitary gigantism
0.000 0.945 0.055
E28.2 Polycystic ovarian syndrome
0.000 0.945 0.054
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.053 0.947 0.000
N18.4 Chronic kidney disease, stage 4
0.000 0.947 0.053
N18.2 Chronic kidney disease, stage 2
0.000 0.948 0.052
C83.6 Undifferentiated (diffuse)
0.000 0.948 0.052
C83.5 Lymphoblastic (diffuse)
0.000 0.948 0.052
C83.4 Immunoblastic (diffuse)
0.000 0.948 0.052
C83.2 Mixed small and large cell (diffuse)
0.000 0.948 0.052
N18.1 Chronic kidney disease, stage 1
0.000 0.949 0.051
E23.2 Diabetes insipidus
0.000 0.949 0.050
E34.0 Carcinoid syndrome
0.000 0.949 0.050
C83.1 Small cleaved cell (diffuse)
0.000 0.950 0.050
C86 Other specified types of T/NK-cell lymphoma
0.000 0.950 0.050
C83.0 Small cell (diffuse)
0.000 0.950 0.050
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.950 0.050
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.950 0.049
C85.0 Lymphosarcoma
0.000 0.950 0.049
K50-K52 Noninfective enteritis and colitis
0.048 0.951 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.952 0.048

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.